Cost Effectiveness and Resource Allocation

Papers
(The H4-Index of Cost Effectiveness and Resource Allocation is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Third-line multiple myeloma treatment of inpatients in a German cancer center: analysis of potential cost savings due to decreased renal insufficiency91
Comparison of current relative value unit-based prices and utility between common surgical procedures, including orthopedic surgeries, in South Korea84
Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value52
Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia37
Quantifying the direct cost benefits of vestibular telemetry using the CAVA system to diagnose the causes of dizziness36
Willingness to pay for cataract surgery and its associated factors in selected medical centers in Urmia, Iran36
Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique33
Cost-effectiveness analysis of coronary arteries bypass grafting (CABG) and percutaneous coronary intervention (PCI) through drug stent in iran: a comparative study32
A cost-effectiveness analysis of the combination of serplulimab with chemotherapy for advanced esophageal squamous cell carcinoma: insights from the ASTRUM-007 trial23
Use of real-world evidence to support regulatory decisions on medical devices in China and a unique opportunity to gain accelerated approval in “Boao Lecheng Pilot Zone”22
Battle against time for innovative cancer treatment: an updated cost-effectiveness analysis of pemigatinib in intrahepatic cholangiocarcinoma20
Economic burden of knee joint replacement in Iran18
Prescription cost analysis and economic impact of drug treatment in patients with chronic illness, attending the medicine out-patient department in a tertiary care hospital at South Delhi18
The use of cost-effectiveness analysis for health benefit package design – should countries follow a sectoral, incremental or hybrid approach?18
In situ breast cancer surgeries in Sweden: lumpectomy or mastectomy?—a cost-effectiveness analysis over a 30-Year period using Markov model17
Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening16
Benefit-cost analysis of nonprofit cataract surgery services in Latin America: a multinational evaluation through an SROI lens16
Cost-effectiveness of implant movement analysis in aseptic loosening after hip replacement: a health-economic model16
The relative cost-effectiveness of atraumatic needles compared to conventional needles in diagnostic lumbar punctures16
0.19522094726562